CCAAT/enhancer binding protein β regulates expression of matrix metalloproteinase-3 in arthritis

Hidetoshi Tsushima, Ken Okazaki, Mitsumasa Hayashida, Takahiro Ushijima, Yukihide Iwamoto

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objectives: To investigate whether CCAAT/enhancer binding protein β (C/EBPβ) mediates the expression of matrix metalloproteinase-3 (MMP-3) and aggrecanases in arthritis. Methods: Localisation of C/EBPβ and MMP-3 in synovium and cartilage from patients with rheumatoid arthritis and osteoarthritis was determined by immunohistochemistry. Cell lines SW982, C28/I2 and human fibroblast-like synoviocytes stimulated by interleukin 1β (IL-β) were subjected to western blotting and quantitative PCR. Overexpression of C/EBPβ by adenovirus was performed in cells and organ culture of normal cartilage. Knockdown of C/EBPβ by small interference RNA was performed in cells. Activity of the human MMP-3 and aggrecanase-2 ADAMTS-5 (a disintegrin and metalloproteinase with thrombospondin motifs) promoters was analysed by a luciferase assay. To determine whether C/EBPβ directly binds to the MMP-3 or ADAMTS-5 promoter, a chromatin immunoprecipitation assay was performed. Results Immunohistochemistry showed that C/EBPβ and MMP-3 were co-localised in arthritic synovium and cartilage. Western blots revealed increased C/ EBPβ expression in cells treated with IL-1β. Expression of MMP-3, MMP-13 and ADAMTS-5 mRNA was significantly increased by the overexpression of C/EBPβ. C/EBPβ stimulated MMP-3 expression and induced matrix degradation in cartilage explants. C/EBPβ knockdown reduced MMP-3 and ADAMTS-5 expression. C/EBPβ stimulated the 2011 bp MMP-3 promoter and the 1768 bp ADAMTS-5 promoter in a dose-dependent manner. Deletion and mutation analysis of the MMP-3 promoter showed that the C/EBPβ core responsive element was located between -108 bp and -100 bp. The chromatin immunoprecipitation assay showed that C/EBPβ was directly bound to MMP-3 and ADAMTS-5 promoters. Conclusions: These data demonstrate that C/EBPβ is involved in expression of MMP-3 and ADAMTS-5 in arthritic synovium and cartilage.

Original languageEnglish
Pages (from-to)99-107
Number of pages9
JournalAnnals of the Rheumatic Diseases
Volume71
Issue number1
DOIs
Publication statusPublished - Jan 1 2012

Fingerprint

CCAAT-Enhancer-Binding Proteins
Matrix Metalloproteinase 3
Arthritis
Cartilage
Synovial Membrane
Assays
Chromatin Immunoprecipitation
Interleukin-1
Chromatin
Western Blotting
Immunohistochemistry
Thrombospondins
Disintegrins
Sequence Deletion
Organ Culture Techniques
Metalloproteases
Fibroblasts
RNA Interference
Luciferases
Matrix Metalloproteinases

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Allergy

Cite this

CCAAT/enhancer binding protein β regulates expression of matrix metalloproteinase-3 in arthritis. / Tsushima, Hidetoshi; Okazaki, Ken; Hayashida, Mitsumasa; Ushijima, Takahiro; Iwamoto, Yukihide.

In: Annals of the Rheumatic Diseases, Vol. 71, No. 1, 01.01.2012, p. 99-107.

Research output: Contribution to journalArticle

Tsushima, Hidetoshi ; Okazaki, Ken ; Hayashida, Mitsumasa ; Ushijima, Takahiro ; Iwamoto, Yukihide. / CCAAT/enhancer binding protein β regulates expression of matrix metalloproteinase-3 in arthritis. In: Annals of the Rheumatic Diseases. 2012 ; Vol. 71, No. 1. pp. 99-107.
@article{74bf7a057c8b427ab5ca6a4c348535ac,
title = "CCAAT/enhancer binding protein β regulates expression of matrix metalloproteinase-3 in arthritis",
abstract = "Objectives: To investigate whether CCAAT/enhancer binding protein β (C/EBPβ) mediates the expression of matrix metalloproteinase-3 (MMP-3) and aggrecanases in arthritis. Methods: Localisation of C/EBPβ and MMP-3 in synovium and cartilage from patients with rheumatoid arthritis and osteoarthritis was determined by immunohistochemistry. Cell lines SW982, C28/I2 and human fibroblast-like synoviocytes stimulated by interleukin 1β (IL-β) were subjected to western blotting and quantitative PCR. Overexpression of C/EBPβ by adenovirus was performed in cells and organ culture of normal cartilage. Knockdown of C/EBPβ by small interference RNA was performed in cells. Activity of the human MMP-3 and aggrecanase-2 ADAMTS-5 (a disintegrin and metalloproteinase with thrombospondin motifs) promoters was analysed by a luciferase assay. To determine whether C/EBPβ directly binds to the MMP-3 or ADAMTS-5 promoter, a chromatin immunoprecipitation assay was performed. Results Immunohistochemistry showed that C/EBPβ and MMP-3 were co-localised in arthritic synovium and cartilage. Western blots revealed increased C/ EBPβ expression in cells treated with IL-1β. Expression of MMP-3, MMP-13 and ADAMTS-5 mRNA was significantly increased by the overexpression of C/EBPβ. C/EBPβ stimulated MMP-3 expression and induced matrix degradation in cartilage explants. C/EBPβ knockdown reduced MMP-3 and ADAMTS-5 expression. C/EBPβ stimulated the 2011 bp MMP-3 promoter and the 1768 bp ADAMTS-5 promoter in a dose-dependent manner. Deletion and mutation analysis of the MMP-3 promoter showed that the C/EBPβ core responsive element was located between -108 bp and -100 bp. The chromatin immunoprecipitation assay showed that C/EBPβ was directly bound to MMP-3 and ADAMTS-5 promoters. Conclusions: These data demonstrate that C/EBPβ is involved in expression of MMP-3 and ADAMTS-5 in arthritic synovium and cartilage.",
author = "Hidetoshi Tsushima and Ken Okazaki and Mitsumasa Hayashida and Takahiro Ushijima and Yukihide Iwamoto",
year = "2012",
month = "1",
day = "1",
doi = "10.1136/annrheumdis-2011-200061",
language = "English",
volume = "71",
pages = "99--107",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - CCAAT/enhancer binding protein β regulates expression of matrix metalloproteinase-3 in arthritis

AU - Tsushima, Hidetoshi

AU - Okazaki, Ken

AU - Hayashida, Mitsumasa

AU - Ushijima, Takahiro

AU - Iwamoto, Yukihide

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Objectives: To investigate whether CCAAT/enhancer binding protein β (C/EBPβ) mediates the expression of matrix metalloproteinase-3 (MMP-3) and aggrecanases in arthritis. Methods: Localisation of C/EBPβ and MMP-3 in synovium and cartilage from patients with rheumatoid arthritis and osteoarthritis was determined by immunohistochemistry. Cell lines SW982, C28/I2 and human fibroblast-like synoviocytes stimulated by interleukin 1β (IL-β) were subjected to western blotting and quantitative PCR. Overexpression of C/EBPβ by adenovirus was performed in cells and organ culture of normal cartilage. Knockdown of C/EBPβ by small interference RNA was performed in cells. Activity of the human MMP-3 and aggrecanase-2 ADAMTS-5 (a disintegrin and metalloproteinase with thrombospondin motifs) promoters was analysed by a luciferase assay. To determine whether C/EBPβ directly binds to the MMP-3 or ADAMTS-5 promoter, a chromatin immunoprecipitation assay was performed. Results Immunohistochemistry showed that C/EBPβ and MMP-3 were co-localised in arthritic synovium and cartilage. Western blots revealed increased C/ EBPβ expression in cells treated with IL-1β. Expression of MMP-3, MMP-13 and ADAMTS-5 mRNA was significantly increased by the overexpression of C/EBPβ. C/EBPβ stimulated MMP-3 expression and induced matrix degradation in cartilage explants. C/EBPβ knockdown reduced MMP-3 and ADAMTS-5 expression. C/EBPβ stimulated the 2011 bp MMP-3 promoter and the 1768 bp ADAMTS-5 promoter in a dose-dependent manner. Deletion and mutation analysis of the MMP-3 promoter showed that the C/EBPβ core responsive element was located between -108 bp and -100 bp. The chromatin immunoprecipitation assay showed that C/EBPβ was directly bound to MMP-3 and ADAMTS-5 promoters. Conclusions: These data demonstrate that C/EBPβ is involved in expression of MMP-3 and ADAMTS-5 in arthritic synovium and cartilage.

AB - Objectives: To investigate whether CCAAT/enhancer binding protein β (C/EBPβ) mediates the expression of matrix metalloproteinase-3 (MMP-3) and aggrecanases in arthritis. Methods: Localisation of C/EBPβ and MMP-3 in synovium and cartilage from patients with rheumatoid arthritis and osteoarthritis was determined by immunohistochemistry. Cell lines SW982, C28/I2 and human fibroblast-like synoviocytes stimulated by interleukin 1β (IL-β) were subjected to western blotting and quantitative PCR. Overexpression of C/EBPβ by adenovirus was performed in cells and organ culture of normal cartilage. Knockdown of C/EBPβ by small interference RNA was performed in cells. Activity of the human MMP-3 and aggrecanase-2 ADAMTS-5 (a disintegrin and metalloproteinase with thrombospondin motifs) promoters was analysed by a luciferase assay. To determine whether C/EBPβ directly binds to the MMP-3 or ADAMTS-5 promoter, a chromatin immunoprecipitation assay was performed. Results Immunohistochemistry showed that C/EBPβ and MMP-3 were co-localised in arthritic synovium and cartilage. Western blots revealed increased C/ EBPβ expression in cells treated with IL-1β. Expression of MMP-3, MMP-13 and ADAMTS-5 mRNA was significantly increased by the overexpression of C/EBPβ. C/EBPβ stimulated MMP-3 expression and induced matrix degradation in cartilage explants. C/EBPβ knockdown reduced MMP-3 and ADAMTS-5 expression. C/EBPβ stimulated the 2011 bp MMP-3 promoter and the 1768 bp ADAMTS-5 promoter in a dose-dependent manner. Deletion and mutation analysis of the MMP-3 promoter showed that the C/EBPβ core responsive element was located between -108 bp and -100 bp. The chromatin immunoprecipitation assay showed that C/EBPβ was directly bound to MMP-3 and ADAMTS-5 promoters. Conclusions: These data demonstrate that C/EBPβ is involved in expression of MMP-3 and ADAMTS-5 in arthritic synovium and cartilage.

UR - http://www.scopus.com/inward/record.url?scp=82955173831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955173831&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2011-200061

DO - 10.1136/annrheumdis-2011-200061

M3 - Article

C2 - 21917825

AN - SCOPUS:82955173831

VL - 71

SP - 99

EP - 107

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 1

ER -